Treatment of Cold Sores

The aim of this study is to determine if a new combination therapy containing lactoferrin (capsule and gel) is safe and well tolerated as a treatment for cold sores. This study also aims to see if this new treatment is as effective as a common treatment (Zovirax cold sore cream). A pilot, open labelled study. All study patients will be randomly allocated to one of two active study treatments. For each participant, one herpetic (cold sore) episode will be assessed. 

Inclusion criteria:

• Healthy subjects at least 18 years of age
• History of recurrent cold sores with at least three episodes in the past year
• Have experienced prodromal (awareness of tingling sensation where lesion appears) symptoms of cold sores during at least half of the previous cold sore episodes
• History of at least half of the cold sore episodes producing classical lesions (i.e. episodes that progressed from blistering through to crusting, scab formation, and healing)
• Subjects must agree to abstain from the use of other topical or oral antiherpetic agents, from anti-inflammatory medications, and from the use of any topical treatments in the area of the lesion (cosmetics, lip balms, and sun screens etc)

To apply contact Renate Morris on (02) 9382 6621 

Back to Clinical Trials- Currently Recruiting